Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

Published

on

demand-for-abuse-deterrent-formulation-technology-skyrocketing-as-opiate-abuse-is-on-the-rise

FinancialNewsMedia.com News Commentary

PALM BEACH, Fla., Sept. 20, 2023 /PRNewswire/ — The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for abuse deterrent formulation technology from the pharmaceutical industry is driving the market growth. Abuse-deterrent formulations are used to decrease the abuse, addiction, and overdose of orally prescribed opioids. The increasing use of abuse deterrent formulations for postoperative pain along with the growing incidence of diseases like cancer is also driving the market growth. A recent report from Global Market Estimates projects that the global abuse deterrent formulation technology market is estimated to witness a high CAGR during the forecast period through 2026.  The report said: “On the basis of drug class, the global abuse deterrent formulation technology market is segmented into opioids, antidepressants, and CNS stimulants. Opioids segment held the largest share and is projected to grow at the highest CAGR during the forecast period. Reducing misuse and abuse is one of the more interesting applications of abuse deterrent formulation. The growing use of opioids for pain has led to the increased availability of these medications in the population across the globe.  On the basis of approach, the market is segmented into physical /chemical barriers, agonist / antagonist combinations, aversion approach, prodrug approach, and abuse-deterrent drug delivery systems among others. Abuse-deterrent drug delivery systems segment held the largest market share and is projected to grow at the highest CAGR during the forecast period. Increase in abuse of controlled substances and resulting overdose deaths is correlated with significant increases in the supply of such medications, including opioids, central nervous system depressants.”  Active companies in the markets this week include: Nutriband Inc. (NASDAQ: NTRB), Clearmind Medicine Inc. (NASDAQ: CMND), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), Cybin Inc. (NYSE American: CYBN), Eli Lilly and Company (NYSE: LLY).

The Global Market report concluded: “North America is expected to dominate the market growth and is expected to grow at the highest CAGR during the forecast period. Rise in research and development activities and increase in prescription of opioid pain medication drugs is expected to boost the market growth in the region.  The European region is also expected to grow at the significant CAGR during the forecast period. Growing number of accidents and increasing number of operations are some of the key factors which are projected to foster market growth during the coming years in the region.”

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology – Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology – Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 11,759,431 for Nutriband’s proprietary AVERSA™ abuse deterrent technology utilizing taste aversion to address the primary routes of abuse of opioid based transdermal patches.

The issuance of this patent, entitled, “Abuse and Misuse Deterrent Transdermal Systems,” further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its proprietary AVERSA™ abuse deterrent technology. This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under development is AVERSA™ Fentanyl, an abuse deterrent fentanyl transdermal system, with the potential to become the first abuse deterrent pain patch on the market. AVERSA™ Fentanyl is estimated to have the potential to reach peak annual U.S. sales of $80M$200M (Health Advances market analysis report 2022.)

“The issuance of this patent covering our AVERSA™ abuse deterrent transdermal technology that utilizes taste aversion to address a primary route of abuse of opioid patches is an important component of our global IP portfolio.” stated Gareth Sheridan, Nutriband CEO. “This new patent strengthens our intellectual property position, which includes patents issued in 45 countries around the world.”  CONTINUED Read this full press release and more news for NTRB at:  https://www.financialnewsmedia.com/news-ntrb.

Other recent developments in the mental health industry of note include:

Clearmind Medicine Inc. (NASDAQ: CMND), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, recently announced that the company has entered into a Clinical Trial Agreement with Johns Hopkins University School of Medicine (“JHU”) to conduct its Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100 (“CMND-100“).

The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-investigators Professor Eric Strain, Director, Behavioral Pharmacology Research Unit, JHU School of Medicine.

“We are honored to collaborate with JHU for our first in human clinical trial. JHU is one of the global leaders in psychedelics clinical research and in researching addictions, and we are very grateful to partner with them to study our proprietary CMND-100 to treat Alcohol Use Disorder,” said Clearmind’s Chief Executive Officer Dr. Adi Zuloff-Shani. “Johns Hopkins is our second US clinical site joining our trial, following Yale School of Medicine’s Department of Psychiatry. We are excited to be working closely with two of the world’s leading medical centers, who have researched our treatment and agreed to participate in our clinical program.”

Advertisement

 

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, recently announced that it has completed enrollment and dosing in Study MMED008, the Company’s Phase 2b study evaluating MM-120 (lysergide D-tartrate) for the treatment of GAD.

“Completion of enrollment of this study is a significant milestone for MindMed and moves us one step closer to our goal of transforming the treatment of GAD for the millions suffering from the disorder,” said Robert Barrow, Chief Executive Officer and Director of MindMed. “Thanks in large part to the enthusiasm we have seen regarding MM-120 among investigators and patients, as well as the strong execution of our team, we were able to enroll almost 200 participants in this trial in just over a year. We anticipate sharing topline results during the fourth quarter of this year.”

Cybin Inc. (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, recently announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,746,088, covering composition of matter for deuterated tryptamine compounds and pharmaceutical compositions thereof, with exclusivity until 2041. The newly granted U.S. patent covers deuterated 5-methoxy-dimethyltryptamine analogs in the Company’s pre-clinical deuterated tryptamine portfolio and further strengthens the Company’s leadership position in the development of potential best-in-class deuterated tryptamine-based therapeutics for the treatment of mental health conditions.

“The grant of this patent is timely as we recently entered into a definitive agreement to acquire Small Pharma Inc., a leading developer of short-duration psychedelic therapeutics, together creating the psychedelic sector’s most impressive and robust intellectual property portfolio. The strong synergy of our collective intellectual property provides an unparalleled opportunity to develop novel, differentiated therapeutics for patients in need of improved treatment options,” said Doug Drysdale, Chief Executive Officer of Cybin. “Looking towards the next chapter for the combined company, this new composition of matter patent will have an important role in protecting the continued advancement of our development pipeline.”

Eli Lilly and Company (NYSE: LLY) involvement with Opioid disorders: Lilly Collaborates with the National Institute on Drug Abuse (NIDA) to Identify Treatments for Opioid Use Disorder (OUD)  – Scientists at Lilly evaluate hundreds of molecules every year, prioritizing and advancing treatments with the strongest likelihood to make life better for people around the globe.

Through Lilly 30×30, we seek to drive our social impact further by improving access to quality healthcare for 30 million people living in resource-limited settings by 2030. Our strategy to accomplish this is through our drug development pipeline, programs to increase access and affordability, and partnerships with nonprofit organizations in the U.S. and abroad.    As part of the Lilly 30×30 pipeline efforts, Lilly is collaborating with NIDA through a Screening Agreement to explore the potential of some early-phase therapies that might be repurposed for the treatment of opioid use disorder (OUD).  

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated forty six hundred dollars for news coverage of the current press releases issued by Nutriband Inc. by the company.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:
Media Contact email:
[email protected]
+1(561)325-8757 

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/demand-for-abuse-deterrent-formulation-technology-skyrocketing-as-opiate-abuse-is-on-the-rise-301933099.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Ford’s Winning Lineup Fuels Record Sales in the Middle East; Sets Stage for Electrified Future

Published

on

ford’s-winning-lineup-fuels-record-sales-in-the-middle-east;-sets-stage-for-electrified-future
  • Record 2024 sales growth in the region driven by strong performance in key markets and Ford’s freshest lineup to date.
  • Mustang Mach-E and Territory Hybrid launches highlight Ford’s commitment to an electrified future in the Middle East.
  • Connected services are also coming to Ford customers in the region, with the 2025 introduction of FordPass™.

DUBAI, UAE, Nov. 7, 2024 /PRNewswire/ — More customers than ever are buying Ford products across the Middle East, thanks to Ford’s extensive and freshest portfolio of vehicles and services for every lifestyle.

 

 

“2024 has been an exceptional year for Ford in the Middle East, with sales having doubled since 2022,” said Ravi Ravichandran, president of Ford Middle East. “This success is due to strong market share gains by our distributors in key countries such as the United Arab Emirates, Kuwait, Bahrain, Qatar and Saudi Arabia.”

In fact, Ford is currently the fastest-growing automotive brand in Saudi Arabia. Al Jazirah Vehicles Agencies and Mohammed Yousef Naghi Motors have accounted for 57 percent of Ford’s total business in the Middle East in the first half of the year.

“The strong performance by all our distributors has contributed to Ford achieving record sales in this important region,” Ravichandran added.

Ford’s strong product momentum comes from 15 nameplates sourced from around the world. Highlights of Ford’s new lineup of products and services include:

2025 Mustang Mach-E: The all-electric Mustang Mach-E premiers in the region next year. This performance-focused electric SUV with space for five adults embodies the Mustang legacy, boasting a 0-100 km/h time of 3.3 seconds. Available with two different battery sizes, the Mach-E has an estimated range of 350-450 Km.

“Mustang Mach E represents a landmark moment for us,” said Kay Hart, president of Ford’s International Markets Group. “It’s our first fully electric vehicle for the region and is truly one of the most exciting vehicles Ford has ever produced.”

Mustang Mach-E will join the F-150, Taurus and Ford Territory hybrids, further solidifying Ford’s commitment to offering a diverse electrified portfolio.

2025 Territory Hybrid: Territory, Ford’s best-selling nameplate in the Middle East, will arrive electrified in 2025. Available across all trims, the Territory Hybrid will combine the popular SUV’s spaciousness, safety features, and convenient design with a fuel-efficient hybrid powertrain, seamlessly blending electric power with the traditional combustion engine for maximized efficiency without compromising performance.

Advertisement

2025 Expedition Tremor: For two decades, customers in the Middle East have bought the full-sized Expedition SUV for its power, capability, convenience, and comfort. The 2025 Expedition takes this legacy even further. Built by off-road experts, it has increased horsepower and torque plus Intelligent 4WD with Terrain Management System and an exclusive Rock Crawl mode. With 33-inch all-terrain tires and 10.6 inches of ground clearance, customers can conquer any terrain – from the deserts of the GCC to the most challenging trail.

Ford Connected Services: Next year Ford will accelerate the launch of Ford Connected Services with the FordPass app first in the UAE, followed by Saudi Arabia.

“FordPass will connect you to your Ford like never before – in a way that puts the ownership experience right in the palm of your hand,” Hart said. “Imagine you’re rushing to a meeting or appointment on a scorching summer day. With FordPass, you can remotely start your car and pre-cool the cabin before you even step outside.”

“Customers in today’s increasingly connected world expect personalised treatment from companies. They want solutions that make them feel productive, cared for and special,” Ravichandran said. “That’s why we’re reimagining every single part of a customer’s ownership journey. Everything we’re doing is to empower customers and make their complicated lives simpler and worry-free.”

That means offering convenient services such as online booking, pickup and delivery options in some markets. There’s also Express Service for routine maintenance so customers can get back on the road with minimal disruption to their day.

Ford’s commitment also includes establishing a new parts distribution center in the UAE, scheduled to open in January 2025. This new center will allow quicker delivery of parts to distributors, allowing Ford owners to get back on the road more quickly.

“Our lineup of innovative products and services shows just how committed Ford is to our customers, our distributors, our employees and our communities across the Middle East,” Hart said.

About Ford Motor Company
Ford Motor Company (NYSE: F) is a global company, committed to helping build a better world, where every person is free to move and pursue their dreams. The company’s Ford+ plan for growth and value creation combines existing strengths, new capabilities and always-on relationships with customers to enrich experiences for customers and deepen their loyalty. Ford develops and delivers innovative, must-have Ford trucks, sport utility vehicles, commercial vans and cars and Lincoln luxury vehicles, along with connected services. The company does that through three customer-centered business segments: Ford Blue, engineering iconic gas-powered and hybrid vehicles; Ford Model e, inventing breakthrough electric vehicles along with embedded software that defines exceptional digital experiences for all customers; and Ford Pro, helping commercial customers transform and expand their businesses with vehicles and services tailored to their needs. Ford employs about 175,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.

Photo: https://mma.prnewswire.com/media/2551432/Ford_Motor_Company_2025_Mustang_Mach_E.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/fords-winning-lineup-fuels-record-sales-in-the-middle-east-sets-stage-for-electrified-future-302298583.html

Advertisement
Continue Reading

Fintech PR

Powering Progress through Connectivity: GSMA’s Mobile Economy Sub-Saharan Africa Report Calls for Action to Close the Digital Divide

Published

on

powering-progress-through-connectivity:-gsma’s-mobile-economy-sub-saharan-africa-report-calls-for-action-to-close-the-digital-divide

New report highlights opportunities in AI, 5G, and satellite connectivity to bridge a 60% usage gap and unlock $170 Billion in GDP by 2030

NAIROBI, Kenya, Nov. 7, 2024 /PRNewswire/ — The mobile industry’s $140 billion contribution to GDP in 2023 is projected to reach $170 billion by 2030 if key connectivity barriers are addressed. These are insights from the flagship Mobile Economy Sub-Saharan Africa 2024 Report unveiled by GSMA today. Mobile technology is essential in supporting development goals across key sectors like healthcare, education, and finance, driving economic growth by expanding internet access and digital services.

As digitalisation accelerates, the report highlights that 4G expansion is set to drive connectivity, projected to account for half of all connections by 2030. However, a significant coverage gap remains, with 13% of the population still unreached, and a 60% usage gap affecting those who live within coverage areas but face barriers to get online, such as unaffordable devices, limited digital skills, or online safety concerns.

In addition to these connectivity challenges, the region faces high operating costs, inflationary pressures, and energy price volatility. Despite these obstacles, emerging trends such as generative AI and satellite partnerships present innovative solutions to bridge gaps across sectors. Broader API solutions, such as GSMA Open Gateway, which recently launched security APIs in South Africa, are poised to enhance digital security and simplify services as these initiatives expand regionally. Addressing these issues is essential to unlocking the socio-economic potential of mobile connectivity in Sub-Saharan Africa.

“Our findings this year reveal both the extraordinary potential and the challenges facing Sub-Saharan Africa’s mobile ecosystem,” said Angela Wamola, Head of Sub-Saharan Africa, GSMA. “To fully realise the benefits of connectivity, it is essential for operators, policymakers, and stakeholders to address affordability barriers, support infrastructure expansion, and foster collaborations that drive digital inclusion and economic impact.”

Read the full press release here.

Logo: https://mma.prnewswire.com/media/1882833/5011528/GSMA_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/powering-progress-through-connectivity-gsmas-mobile-economy-sub-saharan-africa-report-calls-for-action-to-close-the-digital-divide-302298062.html

Continue Reading

Fintech PR

Capital.com set to double technology team amid strong growth

Published

on

capital.com-set-to-double-technology-team-amid-strong-growth

Global fintech sees trading volumes rise by 20% in Q3, plans to fill 200 new tech roles in the next 12 months

LIMASSOL, Cyprus, Nov. 7, 2024 /PRNewswire/ — Capital.com, the high-growth global trading platform and fintech group whose trading volumes surpassed USD$1trn in 2023, today announced total client trading volumes reached over $450 billion in Q3 2024, a 20% increase from Q2 2024, affirming the company’s steady growth trajectory. Over the same period, new user accounts were up by 9%, and the total number of trades executed on the platform grew by 19% to 31 million from the previous quarter.

“Our Q3 results highlight the sustained growth of our platform as we continue to deliver the best trading experience for our clients globally. Supported by our strong track record and growth metrics, we have ambitions to further diversify our product offering and develop pioneering technologies that enhance efficiency across our award-winning platform,” said Dana Massey, Chief Marketing, Product & Technology Officer, Capital.com

Increased trading in Q3 was driven by strong interest in indices, commodities, and FX markets. Index trading was particularly robust, accounting for approximately 53% of all trading volumes, supported by significant activity from clients across the Middle East, followed closely by Europe. Commenting on clients’ trading behaviour in Q3, Daniela Sabin Hathorn, Senior Market Analyst, Capital.com, said:

“With anticipation for the US presidential elections building in Q3 we’ve seen increased interest in indices and FX pairs, specifically those that included the dollar. The capital injection on behalf of China to revive its struggling economy was also a key driver of the momentum in equities throughout the month of September as traders pushed aside concerns about growth in China. Other key events include the market meltdown and then, following the subsequent recovery in stocks, the worse-than-anticipated jobs data during the summer months, which triggered the Sahm rule and brought on concerns about the Federal Reserve being too restrictive for too long. As economic data has improved, so has sentiment in equity markets, with the key global indices starting Q4 close to record highs.”

Building on the platform’s strong client engagement and trading activity in the last quarter, Capital.com is ramping up its investment in technology, with plans to double its technology & engineering in the next 12 months. To support its clients with a diverse range of products and solutions, the company is hiring 200 new professionals across its global network of offices.

“As a tech-first company, expanding our engineering team is crucial to scaling our services and meeting the demands of our growing global client base,” added Massey. “We’re looking to bring on top talent from around the world across engineering, technology support, and development to ensure Capital.com remains at the forefront of fintech innovation.”

Capital.com’s hiring drive is focused on key areas including Java and Angular Software Engineering, DevOps, QA Engineering, Site Reliability Engineering (SRE), Incident Management, Tech Support, IT Services, Data Engineering, Database Administration, and Engineering Management. These roles offer both in-office and remote opportunities across London, Warsaw, Limassol and the company’s other key tech hubs globally, providing an agile and collaborative environment for innovation.

For more information about Capital.com’s technology team hires, please visit: https://capital.com/tech-recruitment

Capital.com is a leading trading and fintech platform that is redefining the future of trading. Founded by Viktor Prokopenya and based in Cyprus, Capital.com is committed to providing a safe, secure, and transparent platform, underpinned by cutting-edge technology and comprehensive education. With offices in eight locations globally and over 700 employees, Capital.com empowers individuals worldwide with the tools and knowledge to trade confidently.

Advertisement

Notes to Editors

About Capital.com

Capital.com is a high-growth fintech company empowering people to participate in financial markets through simple and innovative online trading platforms. Launched in 2016, its intuitive award-winning platform —available on web and app —enables investors to trade thousands of world-renowned markets. To help investors trade with confidence, the platform is fitted with robust risk management controls, transparent pricing and extensive educational content to support clients in their trading journeys.

Capital.com has a global network with offices located in leading business and financial centres including London, Dubai, Warsaw, Vilnius, Sofia, Limassol, and Melbourne. Capital Com (UK) Limited is authorised and regulated by the Financial Conduct Authority (FCA) under registration number 793714. Capital Com SV Investments Limited is Authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a Company registered in the Commonwealth of The Bahamas and authorised to carry out Securities Business by the Securities Commission of The Bahamas with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

To find out more, please visit:  www.capital.com

This press release is for media use only. It’s not intended for individual investors, and doesn’t include personal advice or recommendations.

DISCLAIMER

Spread bets and/or CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading spread bets and/or CFDs with this provider. You should consider whether you understand how spread bets and/or CFDs work and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk.

Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd. Spread bets are available only to UK clients.

The value of shares and ETFs bought through a share dealing account can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.

Advertisement

Capital Com (UK) Limited (“CCUK”) is registered in England and Wales with company registration number 10506220. CCUK is authorised and regulated by the Financial Conduct Authority (“FCA”), under registration number 793714. Capital Com SV Investments Limited (“CCSV”) is registered in Cyprus with company registration number 354252. CCSV is regulated by Cyprus Securities and Exchange Commission (CySEC) under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a limited liability company (company number 209236B) registered in the Commonwealth of The Bahamas and authorised to carry on Securities Business by the Securities by the Securities Commission of The Bahamas (“SCB”) with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.

Logo: https://mma.prnewswire.com/media/2507973/5010856/Capital_com.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/capitalcom-set-to-double-technology-team-amid-strong-growth-302298010.html

Continue Reading

Trending